Intermittent fasting may reduce the risk of blood clots and cardiovascular disease by inhibiting platelet activation.

Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.

A newly published review in Genes & Diseases explores the oncogenic activation of PIK3CA in cancer and highlights emerging ...